A personalized prediction model for urinary tract infections in type 2 diabetes mellitus using machine learning

被引:2
作者
Xiong, Yu [1 ]
Liu, Yu-Meng [2 ]
Hu, Jia-Qiang [3 ]
Zhu, Bao-Qiang [3 ,4 ]
Wei, Yuan-Kui [3 ]
Yang, Yan [5 ,6 ]
Wu, Xing-Wei [3 ]
Long, En-Wu [3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing, Peoples R China
[2] Army Med Univ, Daping Hosp, Dept Pharm, Chongqing, Peoples R China
[3] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Pharm, Personalized Drug Therapy Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China
[4] Southwest Med Univ, Sch Pharm, Luzhou, Sichuan, Peoples R China
[5] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China
[6] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu 610072, Sichuan, Peoples R China
关键词
type 2 diabetes mellitus; urinary tract infections; machine learning; predictive models; individualized therapy; COTRANSPORTER; 2; INHIBITORS; RISK-FACTORS; PREVALENCE; EPIDEMIOLOGY; METAANALYSIS; IMPACT;
D O I
10.3389/fphar.2023.1259596
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Patients with type 2 diabetes mellitus (T2DM) are at higher risk for urinary tract infections (UTIs), which greatly impacts their quality of life. Developing a risk prediction model to identify high-risk patients for UTIs in those with T2DM and assisting clinical decision-making can help reduce the incidence of UTIs in T2DM patients. To construct the predictive model, potential relevant variables were first selected from the reference literature, and then data was extracted from the Hospital Information System (HIS) of the Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital for analysis. The data set was split into a training set and a test set in an 8:2 ratio. To handle the data and establish risk warning models, four imputation methods, four balancing methods, three feature screening methods, and eighteen machine learning algorithms were employed. A 10-fold cross-validation technique was applied to internally validate the training set, while the bootstrap method was used for external validation in the test set. The area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA) were used to evaluate the performance of the models. The contributions of features were interpreted using the SHapley Additive ExPlanation (SHAP) approach. And a web-based prediction platform for UTIs in T2DM was constructed by Flask framework. Finally, 106 variables were identified for analysis from a total of 119 literature sources, and 1340 patients were included in the study. After comprehensive data preprocessing, a total of 48 datasets were generated, and 864 risk warning models were constructed based on various balancing methods, feature selection techniques, and a range of machine learning algorithms. The receiver operating characteristic (ROC) curves were used to assess the performances of these models, and the best model achieved an impressive AUC of 0.9789 upon external validation. Notably, the most critical factors contributing to UTIs in T2DM patients were found to be UTIs-related inflammatory markers, medication use, mainly SGLT2 inhibitors, severity of comorbidities, blood routine indicators, as well as other factors such as length of hospital stay and estimated glomerular filtration rate (eGFR). Furthermore, the SHAP method was utilized to interpret the contribution of each feature to the model. And based on the optimal predictive model a user-friendly prediction platform for UTIs in T2DM was built to assist clinicians in making clinical decisions. The machine learning model-based prediction system developed in this study exhibited favorable predictive ability and promising clinical utility. The web-based prediction platform, combined with the professional judgment of clinicians, can assist to make better clinical decisions.
引用
收藏
页数:11
相关论文
共 50 条
[1]  
Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc14-S081, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc11-S062, 10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc12-s011]
[2]   Development of the Catheter-Associated Urinary Tract Infections Control Precautions Scale [J].
Arli, Senay Karadag ;
Bakan, Ayse Berivan .
JOURNAL OF CONTINUING EDUCATION IN NURSING, 2018, 49 (11) :507-513
[3]   Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials [J].
Berhan, Asres ;
Barker, Alex .
BMC ENDOCRINE DISORDERS, 2013, 13
[4]   Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis [J].
Carrillo-Larco, Rodrigo M. ;
Anza-Ramirez, Cecilia ;
Saal-Zapata, Giancarlo ;
Villarreal-Zegarra, David ;
Zafra-Tanaka, Jessica Hanae ;
Ugarte-Gil, Cesar ;
Bernabe-Ortiz, Antonio .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2022, 76 (01) :75-84
[5]  
Carrondo Maria Cristina, 2020, Obes Med, V17, P100190, DOI 10.1016/j.obmed.2020.100190
[6]   Urinary Tract Infections 2021 Update [J].
Chenoweth, Carol E. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) :857-870
[7]   An in-vitro urinary catheterization model that approximates clinical conditions for evaluation of innovations to prevent catheter-associated urinary tract infections [J].
Chua, R. Y. R. ;
Lim, K. ;
Leong, S. S. J. ;
Tambyah, P. A. ;
Ho, B. .
JOURNAL OF HOSPITAL INFECTION, 2017, 97 (01) :66-73
[8]   Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes [J].
Clar, Christine ;
Gill, James Alexander ;
Court, Rachel ;
Waugh, Norman .
BMJ OPEN, 2012, 2 (05)
[9]   Urinary tract infection in women [J].
Czajkowski, Krzysztof ;
Bros-Konopielko, Magdalena ;
Teliga-Czajkowska, Justyna .
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2021, 20 (01) :40-47
[10]   Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections A Population-Based Cohort Study [J].
Dave, Chintan V. ;
Schneeweiss, Sebastian ;
Kim, Dae ;
Fralick, Michael ;
Tong, Angela ;
Patorno, Elisabetta .
ANNALS OF INTERNAL MEDICINE, 2019, 171 (04) :248-+